Effect of mizoribine on collagen-induced arthritis in mice

Japanese Journal of Pharmacology

Volumn 70, Issue 2, 1996, Pages 169-175

  Kamada, Hiroyuki ^a   Nakagami, Keiji ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

Cellular immunity; Collagen induced arthritis; Immunomodulator; Mizoribine; Steroid

Indexed keywords

BUCILLAMINE; COLLAGEN; COLLAGEN ANTIBODY; MIZORIBINE; PENICILLAMINE; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BONE INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SPLEEN LYMPHOCYTE;

EID: 0029962214     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.70.169     Document Type: Article

References (26)

1. Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Asano K and Matsuda T: Studies on bredinin: Isolation, characterization and biological properties. J Antibiot (Tokyo) 27, 775-782 (1974)
2. Kamata K, Okubo M, Ishigamori E, Masaki Y, Uchida H, Watanabe K and Kashiwagi N: Immunosuppressive effect of bredinin on cell-mediated and humoral immune reactions in experimental animals. Transplantation 35, 144-149 (1983)
3. Okubo M, Chen X-M, Kamata K, Masaki Y and Uchiyama T: Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice. Transplantation 41, 495-498 (1986)
4. Kusumi T, Tsuda M, Katsunuma T and Yamamura M: Dual inhibitory effect of bredinin. Cell Biochem Funct 7, 201-204 (1988)
5. Shiokawa Y, Honma M, Shichikawa K, Miyamoto T, Hirose J, Nobunaga T, Mizushima Y, Sugawara S, Warabi H, Kondo H and Ogawa N: Clinical effectiveness of mizoribine on rheumatoid arthritis: A double-blind comparative study using lobenzarit disodium as a standard drug. Jpn J Inflamm 11, 375-390 (1991) (Abstr in English)
6. Tajima A, Hata M, Ohta N, Ohtawara Y, Suzuki K and Aso Y: Bredinin treatment in clinical kidney allografting. Transplantation 38, 116-118 (1984)
7. Aso K, Uchida H, Sato K, Yokota K, Osakabe T, Nakayama Y, Ohkubo M, Kumano K, Endo T, Koshiba K, Watanabe K and Kashiwagi N: Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone. Transplant Proc 19, 1955-1958 (1987)
8. Osakabe T, Uchida H, Masaki Y, Yokota K, Sato K, Nakayama Y, Ohkubo M, Kumano K, Endo T, Watanabe K and Aso K: Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation. Transplant Proc 21, 1598-1600 (1989)
9. Kondo H, Okada J and Kashiwazaki S: Clinical trial of long-term administration of mizoribine in the treatment of lupus nephritis. Clin Immunol 21, 643-650 (1989) (Abstr in English)
10. Iwata H, Iwaki H, Matsukawa T, Kasamatsu S and Okamoto H: Anti-arthritic activity of bredinin, an immunosuppressive agent. Separatum Exp 33, 502-503 (1977)
11. Tsujino M, Ishikawa H and Mizuno K: Effect of mizoribine on adjuvant and collagen arthritis rat. Jpn J Inflamm 10, 63-66 (1990) (Abstr in English)
12. Ishikawa H and Shibata K: Effect of mizoribine on adjuvant arthritis in rat. Jpn J Inflamm 11, 507-511 (1991) (Abstr in English)
13. Kobayashi T, Abe C and Hirose S: Therapeutic effect of mizoribine on spontaneous autoimmune disorders in MRL/Mp-lpr/lpr mice. Jpn J Inflamm 12, 193-197 (1992) (Abstr in English)
14. Kakimoto K, Katsumi M, Hirofuji T, Iwata H and Koga T: Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J Immunol 140, 78-83 (1988)
15. Stuart JM and Dixon FJ: Serum transfer of collagen-induced arthritis in mice. J Exp Med 158, 378-392 (1983)
16. Takagishi K, Kaibara N, Hotokebuchi T, Arita C, Morinaga M and Arai K: Effects of cyclosporin on collagen induced arthritis in mice. Ann Rheum Dis 45, 339-344 (1986)
17. Cannon GW, McCall S, Cole BC, Griffiths MM, Radov LA and Ward JR: Effects of indomethacin, cyclosporin, cyclophosphamide, and placebo on collagen-induced arthritis of mice. Agents Actions 29, 315-323 (1990)
18. Paska W, McDonald KJ and Croft M: Studies on type II collagen induced arthritis in mice. Agents Actions 18, 413-420 (1986)
19. Rordorf C, Pataki A, Nogues V, Schlager F, Feige U and Glatt M: Arthritis in MRL/lpr mice and in collagen II sensitized DBA-1 mice and their use in pharmacology. Int J Tissue React 9, 341-347 (1987)
20. Phadke K, Fouts RL, Parrish JE and Butler LD: Evaluation of the effects of various anti-arthritic drugs on type II collagen-induced mouse arthritis model. Immunopharmacology 10, 51-60 (1985)
21. Imaizumi K, Hinoue H, Ueno M, Takata I, Sato T, Minato Y, Takeshita M and Okaniwa A: Pathological evaluation of antirheumatic drugs on type II collagen-induced arthritis in DBA/1J mouse. Exp Anim 40, 95-99 (1991)
22. Stuart JM, Townes AS and Kang AH: Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 69, 673-683 (1982)
23. Takagishi K, Kaibara N, Hotokebuchi T, Arita C, Morinaga M and Arai K: Serum transfer of collagen arthritis in congenitally athymic nude rats. J Immunol 134, 3864-3867 (1985)
24. Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, Ogawa T, Hamaoka T, Senoh H and Fujiwara H: Type II collagen-induced murine arthritis: I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 140, 1477-1484 (1988)
25. Ichikawa Y, Ihara H, Takahara S, Takada K, Shrestha GR, Ishibashi M, Arima M, Sagawa S and Sonoda T: The immunosuppressive mode of action of mizoribine. Transplantation 38, 262-267 (1984)
26. Nagai H, Takaoka Y, Kamada H and Mori H: The model of arthritis induced by superantigen in mice. Life Sci 55, 233-237 (1994)